| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 3 | 5 | 2012 | 2019 | ||||||||
|
SMAD family member 3 | 0.415 | 0.923 | 0.80 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
TIMP metallopeptidase inhibitor 3 | 0.445 | 0.923 | 0.63 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
aryl hydrocarbon receptor nuclear translocator like | 0.510 | 0.885 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 4 | 2 | 2016 | 2019 | ||||||||
|
FTO alpha-ketoglutarate dependent dioxygenase | 0.486 | 0.885 | 8.4E-08 |
|
phenotype | 0.100 | None | 1.000 | 4 | 4 | 2012 | 2018 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2010 | 2018 | ||||||||
|
hepatitis A virus cellular receptor 1 | 0.489 | 0.885 | 8.5E-07 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2015 | 2018 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2018 | ||||||||
|
phospholipase A2 group VI | 0.476 | 0.846 | 2.5E-10 |
|
phenotype | 0.100 | None | 1.000 | 7 | 6 | 2010 | 2019 | ||||||||
|
insulin receptor | 0.432 | 0.846 | 3.6E-05 |
|
phenotype | 0.100 | None | 1.000 | 5 | 4 | 2012 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.100 | None | 1.000 | 3 | 6 | 2009 | 2019 | ||||||||
|
aldo-keto reductase family 1 member C4 | 0.587 | 0.846 | 2.2E-17 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2013 | 2017 | ||||||||
|
cathepsin B | 0.457 | 0.846 | 5.9E-11 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2018 | ||||||||
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
GATA binding protein 4 | 0.458 | 0.846 | 0.49 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
SPARC related modular calcium binding 1 | 0.565 | 0.846 | 9.5E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
solute carrier family 22 member 3 | 0.531 | 0.846 | 7.8E-10 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2016 | ||||||||
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 0.482 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2018 | ||||||||
|
calcitonin receptor | 0.464 | 0.846 | 3.1E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
phenotype | 0.100 | None | 1.000 | 15 | 11 | 2007 | 2019 |